{
    "applicationNumber": "BR 11 2021 022335-5",
    "filingDate": "12/05/2020",
    "grantDate": null,
    "title": "FORMAS CRISTALINAS DE N-(3-(2-(2-HIDROXIETOXI)-6-MORFOLINOPIRIDIN-4-IL)-4-METILFENIL)-2 (TRIFLUOROME-TIL)ISONICOTINAMIDA COMO INIBIDORES RAF PARA O TRATAMENTO DE C\u00c2NCER",
    "nationalPhaseDate": [
        "08/11/2021"
    ],
    "internationalApplication": {
        "pctNumber": "PCT IB2020/054491",
        "pctDate": "12/05/2020",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "CN",
            "priorityNumber": "PCT/CN2019/086595",
            "priorityDate": "13/05/2019"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2655"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2660"
        }
    ],
    "inventors": [
        "CORNELIUS STEPHEN HARLACHER",
        "ZAIXING LI",
        "LILADHAR MURLIDHAR WAYKOLE"
    ],
    "holders": [
        79188
    ],
    "ipcCodes": [
        "A61P 35/00",
        "A61K 31/5375",
        "C07D 413/14"
    ]
}